NCT05779670 Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
| NCT ID | NCT05779670 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Osteosarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to describe adherence to a personalised home exercise program in patients undergoing resection and reconstruction of lower limb for bone tumor and neoadjuvant chemotherapy treatment in the first six months after surgery intervention and investigate possible prognostic factors.
Eligibility Criteria
Inclusion Criteria: * patients aged 12 years with bone tumor undergoing surgery (resection and reconstruction of the lower limb) and in adjuvant treatment * patients under physiotherapy treatment Exclusion Criteria: * patients with difficulties in understanding the Italian language * patients not using digital services
Contact & Investigator
alida abbruzzese
PRINCIPAL INVESTIGATOR
ufficio ricerca professioni sanitarie
Frequently Asked Questions
Who can join the NCT05779670 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 90 Years, studying Osteosarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05779670 currently recruiting?
Yes, NCT05779670 is actively recruiting participants. Contact the research team at alida.abbruzzese@ior.it for enrollment information.
Where is the NCT05779670 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT05779670 clinical trial?
NCT05779670 is sponsored by Istituto Ortopedico Rizzoli. The principal investigator is alida abbruzzese at ufficio ricerca professioni sanitarie. The trial plans to enroll 50 participants.